Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
Trial
N/A
Completed
Sept. 11, 2017
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
Trial
N/A
Completed
Sept. 6, 2017
Evaluating the Influence of Externally vs. Internally Focused Exercise on Rehabilitation in Parkinson's Disease
Trial
N/A
Completed
Aug. 30, 2017
Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy
Trial
N/A
Terminated
Aug. 27, 2017
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067
Trial
Phase 1
Completed
Aug. 23, 2017
Sub-thalamic Nucleus Stimulation in Parkinson Disease
Trial
N/A
Completed
Aug. 23, 2017
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
Trial
Phase 4
Unknown
Aug. 22, 2017
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
Trial
Phase 3
Completed
Aug. 21, 2017
Deep Brain Stimulation for Parkinson's Disease: the Globus Pallidus Internus Versus Subthalamic Nucleus
Trial
N/A
Unknown
Aug. 16, 2017
Systemic Synuclein Sampling Study (S4)
Trial
N/A
Completed
Aug. 16, 2017
Action Observation Plus Sonification Therapeutic Protocol
Trial
N/A
Completed
Aug. 14, 2017
The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease
Trial
Phase 1
Completed
Aug. 13, 2017
Motion Immune Magnetic Resonance Imaging (MRI)
Trial
N/A
Completed
Aug. 10, 2017
Somatosensory Dysfunction as the Underlying Mechanism of Upper Limbs Motor Blocks in People With Parkinson's Disease
Trial
N/A
Completed
Aug. 7, 2017
Study to Evaluate SYN115 in Parkinson's Disease
Trial
Phase 2
Completed
Aug. 7, 2017
Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery
Trial
N/A
Completed
Aug. 2, 2017
Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease
Trial
N/A
Completed
Aug. 2, 2017
Dance for People With Parkinson's Disease
Trial
N/A
Unknown
Aug. 2, 2017
Intranasal Glutathione in Parkinson's Disease
Trial
Phase 1
Completed
July 30, 2017